CLINICAL_TRIALS
trial_result
· 2019-12-03
Clinical Trial Update: Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial update of trametinib in patients with NF1-mutant non-small cell lung cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-12-03